Doris Barcellona/Fondazione Arianna Anticoagulazione
Aug 22, 2025, 03:37
Lupus Anticoagulant-Hypoprothrombinemia Syndrome: Review by Doris Barcellona and Colleagues
Maria Filomena Ruberto, Biologist specialized in Clinical Pathology and Clinical Biochemistry and II Level Master’s degree in Hemostasis and Thrombosis, shared on LinkedIn:
”Doris Barcellona et al.Lupus Anticoagulant-hypoprothrombinemia Syndrome: A Review Enriched by a New Particular Patient. Semin Thromb Hemost. 2025.”
Read the full article here.
Article: Lupus Anticoagulant-hypoprothrombinemia Syndrome: A Review Enriched by a New Particular Patient
Authors: Doris Barcellona , Antonella Mameli , Roberta Montisci , Maria Filomena Ruberto , Lara Fenu , Francesco Marongiu
Stay updated on all scientific advances in the field of bleeding disorders with Hemostasis Today.
-
Oct 9, 2026, 16:23David Boone: Distinguishing Stroke Prevention from Rhythm Control in Atrial Fibrillation
-
Oct 9, 2026, 15:27Mohamed Hegazi: Geostatistical Modelling Maps Global β-Thalassaemia Carrier Prevalence
-
Oct 9, 2026, 15:15Maha Othman: Uncovering the Consensus on TXA in TBI – Call for Collaboration on a Landmark Umbrella Review
-
Oct 9, 2026, 15:07Daniel D. Han: How Inhalation Product Exposure Impairs Cardiac and Platelet Recovery After MI
-
Oct 9, 2026, 14:58William Toole: How Ultrasound-Guided PRP Therapy Relieves Joint and Tendon Pain
-
Oct 9, 2026, 14:50Shayan Mohammadmoradi: In Corpus Christi for the 20th Midwest Platelet Conference
-
Oct 9, 2026, 14:37Tariq Tramboo: High Platelet Concentrate for Osteoarthritis Knee – Recent Meta-Analyses
-
Oct 9, 2026, 14:26Yousma Khan: Hematology Series – Beyond RBCs, WBCs and Platelets
-
Oct 9, 2026, 14:13Jesus Ardila Novoa: Why the WHO’s Historic Essential Medicines List Decision Is Just the Beginning